Plunkett Research Online: Magenta Therapeutics Inc

MAGENTA THERAPEUTICS INC (MGTA) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Magenta Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing novel medicines to extend the curative power of stem cell transplant, gene therapy, genome editing, and cell therapy. The pipeline of the company includes MGTA-117, MGTA-145, and others......


MAGENTA THERAPEUTICS INC

Ticker: MGTA
Exchange: NAS
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 857 242-0170
Fax:
Address: 100 Technology Square 5th Floor
Cambridge, MA 2139 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Contacts Description

Jason GardnerCEO/Co-Founder/Director/President
Steve MahoneyCFO/Chief Accounting Officer/COO/Treasurer
See More
Magenta Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing novel medicines to extend the curative power of stem cell transplant, gene therapy, genome editing, and cell therapy. The pipeline of the company includes MGTA-117, MGTA-145, and others......See More See More

$USD, In whole numbers2020201920182017201620152014
Sales
Profits
Brands, Divisions and Affiliates Top Salaries
Salary
Bonus
Other Thoughts Corporate Culture